menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Emerging New Therapies for Multiple Sclerosis Patients

Program Information
Recommended
Emerging New Therapies for Multiple Sclerosis Patients
RestartResume
For years, patients with multiple sclerosis have had to rely on injectable medications. But several new oral medications are emerging, and one drug...
  • Overview

    For years, patients with multiple sclerosis have had to rely on injectable medications. But several new oral medications are emerging, and one drug has already been approved by the FDA. Why has it taken so long to develop oral formulations? Dr. Jeffrey Cohen, director of the Millen Experimental Therapeutics program at the Cleveland Clinic and professor of medicine at the Cleveland Clinic Lerner College of Medicine, joins host Dr. Anthony Alessi to discuss how these new drugs work, the side effects, and which patients can most benefit from new oral therapy.

    Produced in cooperation with:

    AAN Logo

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 7/18/19

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.